Fundraising FoxCyto-Facto
3 known investors
Find your way into Cyto-Facto
Sign up to find every way you can get introduced to Cyto-Facto
- Your email: who you already know at Cyto-Facto, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Cyto-Facto team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Cytofacto appears to be a Japanese startup involved in cell therapy / regenerative medicine, engaging in contract manufacturing of cell-based products (e.g. an agreement regarding manufacturing of "Stemchymal"). The page does not provide a full description of the company's offerings.
Investors · 3
Frequently asked questions
- What does Cyto-Facto do?
- Cytofacto appears to be a Japanese startup involved in cell therapy / regenerative medicine, engaging in contract manufacturing of cell-based products (e.g. an agreement regarding manufacturing of "Stemchymal"). The page does not provide a full description of the company's offerings.
- Who are Cyto-Facto's investors?
- Cyto-Facto's investors include Asahi Kasei Corporate Venture Capital, Kobe University Capital, MPower.